Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) Study
Open Access
- 15 October 2011
- journal article
- research article
- Published by American Diabetes Association in Diabetes Care
- Vol. 34 (11), 2403-2405
- https://doi.org/10.2337/dc11-1248
Abstract
OBJECTIVE: To examine the effects of crossing over from optimized multiple daily injection (MDI) therapy to sensor-augmented pump (SAP) therapy for 6 months, and the effects of 18 months’ sustained use of SAP. RESEARCH DESIGN AND METHODS: The 6-month, single-crossover continuation phase of Sensor-Augmented Pump Therapy for A1C Reduction (STAR 3) provided SAP therapy to 420 subjects who completed the 1-year randomized study. The primary outcome was change in A1C in the crossover group. RESULTS: A1C values were initially lower in the continuing-SAP group than in the crossover group (7.4 vs. 8.0%, P < 0.001). A1C values remained reduced in the SAP group. After 3 months on the SAP system, A1C decreased to 7.6% in the crossover group (P < 0.001); this was a significant and sustained decrease among both adults and children (P < 0.05). CONCLUSIONS: Switching from optimized MDI to SAP therapy allowed for rapid and safe A1C reductions. Glycemic benefits of SAP therapy persist for at least 18 months.Keywords
This publication has 8 references indexed in Scilit:
- Usage and Effectiveness of the Low Glucose Suspend Feature of the Medtronic Paradigm Veo Insulin PumpJournal of Diabetes Science and Technology, 2011
- Effectiveness of sensor-augmented pump therapy in children and adolescents with type 1 diabetes in the STAR 3 studyPediatric Diabetes, 2011
- Effectiveness of Sensor-Augmented Insulin-Pump Therapy in Type 1 DiabetesThe New England Journal of Medicine, 2010
- STAR 3 Randomized Controlled Trial to Compare Sensor-Augmented Insulin Pump Therapy with Multiple Daily Injections in the Treatment of Type 1 Diabetes: Research Design, Methods, and Baseline Characteristics of Enrolled SubjectsDiabetes Technology & Therapeutics, 2010
- Incremental Value of Continuous Glucose Monitoring When Starting Pump Therapy in Patients With Poorly Controlled Type 1 DiabetesDiabetes Care, 2009
- Can We Really Close the Loop and How Soon? Accelerating the Availability of an Artificial Pancreas: A Roadmap to Better Diabetes OutcomesDiabetes Technology & Therapeutics, 2009
- The Use of an Energy Monitor in the Management of Diabetes: A Pilot StudyDiabetes Technology & Therapeutics, 2009
- Defining and Reporting Hypoglycemia in DiabetesDiabetes Care, 2005